Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TapImmune Inc (OTCQB:TPIV)

0.575
Delayed Data
As of May 27
 -0.005 / -0.86%
Today’s Change
0.24
Today|||52-Week Range
1.71
-4.17%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues0.000.000.000.00--
 
Operating ExpensesGross Income0.000.000.000.00--
General Expenses1.1M1.7M2.3M1.8M
 
 
 
 
 
Research And Development201.2K769.2K131.4K985.8K
 
 
 
 
 
Total Operating Expenses1.1M1.7M2.3M1.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.1M-1.7M-2.3M-1.8M
 
 
 
 
 
Extraordinary Credit0.004.2M0.000.00
 
 
Extraordinary Charge-17.3M-24.7K-14.9M-3.0M
 
 
 
 
 
Interest Expense On Debt0.000.0010.9K--
 
 
Other Expenses775.000.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-18.4M2.5M-17.1M-4.7M
 
 
 
 
 
Net Income-18.4M2.5M-17.1M-4.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS33.5M48.6M70.6M70.6M
 
 
 
 
 
Shares To Calculate EPS Diluted33.5M80.9M70.6M70.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.55$0.03-$0.24-$0.07
 
 
 
 
 
EPS Diluted-$0.55$0.03-$0.24-$0.07